Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-Tuberculosis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-Tuberculosis Drugmarket, defines the market attractiveness level of Anti-Tuberculosis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-Tuberculosis Drug industry, describes the types of Anti-Tuberculosis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-Tuberculosis Drug market and the development prospects and opportunities of Anti-Tuberculosis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-Tuberculosis Drug market in Chapter 13.
By Player:
Lupin
Abbott
Prizer
Sanofi
Otsuka
NOVARTIS
By Type:
First-Line Anti-Tuberculosis Drugs
Second-Line Anti-Tuberculosis Drugs
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-Tuberculosis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-Tuberculosis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-Tuberculosis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-Tuberculosis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-Tuberculosis Drug Market Analysis and Outlook to 2022
-
7.1 Global Anti-Tuberculosis Drug Consumption (2017-2022)
-
7.2 United States Anti-Tuberculosis Drug Consumption (2017-2022)
-
7.3 Europe Anti-Tuberculosis Drug Consumption (2017-2022)
-
7.4 China Anti-Tuberculosis Drug Consumption (2017-2022)
-
7.5 Japan Anti-Tuberculosis Drug Consumption (2017-2022)
-
7.6 India Anti-Tuberculosis Drug Consumption (2017-2022)
-
7.7 South Korea Anti-Tuberculosis Drug Consumption (2017-2022)
8 Region and Country-wise Anti-Tuberculosis Drug Market Analysis and Outlook to 2028
-
8.1 Global Anti-Tuberculosis Drug Consumption Forecast (2022-2028)
-
8.2 United States Anti-Tuberculosis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Anti-Tuberculosis Drug Consumption Forecast (2022-2028)
-
8.4 China Anti-Tuberculosis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Anti-Tuberculosis Drug Consumption Forecast (2022-2028)
-
8.6 India Anti-Tuberculosis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-Tuberculosis Drug Consumption Forecast (2022-2028)
9 Global Anti-Tuberculosis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-Tuberculosis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global First-Line Anti-Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Second-Line Anti-Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-Tuberculosis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Anti-Tuberculosis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-Tuberculosis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global First-Line Anti-Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Second-Line Anti-Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-Tuberculosis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-Tuberculosis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-Tuberculosis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-Tuberculosis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-Tuberculosis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-Tuberculosis Drug Market Competitive Analysis
-
14.1 Lupin
-
14.1.1 Lupin Company Details
-
14.1.2 Lupin Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Lupin Anti-Tuberculosis Drug Product and Service
-
14.2 Abbott
-
14.2.1 Abbott Company Details
-
14.2.2 Abbott Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbott Anti-Tuberculosis Drug Product and Service
-
14.3 Prizer
-
14.3.1 Prizer Company Details
-
14.3.2 Prizer Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Prizer Anti-Tuberculosis Drug Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Anti-Tuberculosis Drug Product and Service
-
14.5 Otsuka
-
14.5.1 Otsuka Company Details
-
14.5.2 Otsuka Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Otsuka Anti-Tuberculosis Drug Product and Service
-
14.6 NOVARTIS
-
14.6.1 NOVARTIS Company Details
-
14.6.2 NOVARTIS Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 NOVARTIS Anti-Tuberculosis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-Tuberculosis Drug
-
Figure Anti-Tuberculosis Drug Picture
-
Table Global Anti-Tuberculosis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Tuberculosis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Tuberculosis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-Tuberculosis Drug Consumption by Country (2017-2022)
-
Figure United States Anti-Tuberculosis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-Tuberculosis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Anti-Tuberculosis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-Tuberculosis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Anti-Tuberculosis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-Tuberculosis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Tuberculosis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-Tuberculosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-Tuberculosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-Tuberculosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-Tuberculosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-Tuberculosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-Tuberculosis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global First-Line Anti-Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Second-Line Anti-Tuberculosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global First-Line Anti-Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Second-Line Anti-Tuberculosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-Tuberculosis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-Tuberculosis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Lupin (Foundation Year, Company Profile and etc.)
-
Table Lupin Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Anti-Tuberculosis Drug Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Anti-Tuberculosis Drug Product and Service
-
Table Prizer (Foundation Year, Company Profile and etc.)
-
Table Prizer Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prizer Anti-Tuberculosis Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Anti-Tuberculosis Drug Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Anti-Tuberculosis Drug Product and Service
-
Table NOVARTIS (Foundation Year, Company Profile and etc.)
-
Table NOVARTIS Anti-Tuberculosis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table NOVARTIS Anti-Tuberculosis Drug Product and Service
-
